BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17071598)

  • 21. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo.
    Norrby K
    J Vasc Res; 2004; 41(4):293-304. PubMed ID: 15192265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
    Meng N; Zhao J; Zhao B; Cheng Y; Wang W; Zhang Y; Zhang S; Miao J
    J Cell Biochem; 2008 Aug; 104(6):2123-30. PubMed ID: 18393353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiangiogenic properties of gold nanoparticles.
    Mukherjee P; Bhattacharya R; Wang P; Wang L; Basu S; Nagy JA; Atala A; Mukhopadhyay D; Soker S
    Clin Cancer Res; 2005 May; 11(9):3530-4. PubMed ID: 15867256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
    Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
    Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.
    Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH
    Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
    Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
    FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
    Thejass P; Kuttan G
    Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
    Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
    Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis.
    Yi EY; Park SY; Song HS; Son MJ; Yi KY; Yoo SE; Kim YJ
    Exp Mol Med; 2006 Oct; 38(5):502-8. PubMed ID: 17079866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.
    Reis RC; Schuppan D; Barreto AC; Bauer M; Bork JP; Hassler G; Coelho-Sampaio T
    Biochem Biophys Res Commun; 2005 Aug; 333(3):976-83. PubMed ID: 15985216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
    Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1.
    Alavi AS; Acevedo L; Min W; Cheresh DA
    Cancer Res; 2007 Mar; 67(6):2766-72. PubMed ID: 17363598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.
    Delgado VM; Nugnes LG; Colombo LL; Troncoso MF; Fernández MM; Malchiodi EL; Frahm I; Croci DO; Compagno D; Rabinovich GA; Wolfenstein-Todel C; Elola MT
    FASEB J; 2011 Jan; 25(1):242-54. PubMed ID: 20876211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
    Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
    Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.